Pharma Pricing and Reimbursement Forum on May 27-28, 2021 in Budapest, Hungary

Key Takeaways

The latest outcomes of the effects of COVID19 on the delay of new product launch

Can Price Transparency contribute to more affordable patient access to medicines?

Reaching a better integration of regulatory pathways

A look into the personalized reimbursement system

Early Payer Engagement

Equal access and multi-indication medicines